National Cancer Center Hospital East

This study tests whether combining two drugs, nivolumab and lenvatinib, can shrink or control anaplastic thyroid cancer that cannot be removed by surgery. It involves 51 adults with this rare and fast-growing cancer. The main goals are to check safety and see how many patients' t…

This study tests whether giving a combination of three drugs (lenvatinib, pembrolizumab, and FLOT chemotherapy) before and after surgery can help shrink or eliminate stomach cancer in 43 adults. Participants have early-stage stomach cancer that has not spread. The main goal is to…

This study tests whether a combination of targeted drugs (trastuzumab deruxtecan, capecitabine, and durvalumab) can shrink HER2-positive stomach or gastroesophageal junction cancer before surgery and prevent return after surgery. About 64 adults with untreated, advanced but not s…